BELINGARD JEAN-LUC 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Feb 21, 2020
Insider Transaction Report
Form 4
BELINGARD JEAN-LUC
Director
Transactions
- Exercise/Conversion
Common Stock
2020-02-19$77.19/sh+3,100$239,289→ 41,161 total - Sale
Common Stock
2020-02-19$189.76/sh−26,479$5,024,750→ 14,682 total - Exercise/Conversion
Non-qualified Stock Options
2020-02-19−3,100→ 0 totalExercise: $77.19From: 2011-05-12Exp: 2020-05-12→ Common Stock (3,100 underlying)
Footnotes (3)
- [F1]The price of $189.7636 per share represents a weighted average of sales prices ranging from $189.54 to $189.917 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- [F3]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.